SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
405METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDERS Patent number: scaram(o)uche-9/5/2004
404I remember, as a MHC serologist, speaking a language that nobody else understoodscaram(o)uche-9/5/2004
403This Dr. Boscan must be a real riot at parties...... Am J Physiol Regul Integr scaram(o)uche-9/5/2004
402>> Hopefully someone in charge of clinical development does << All scaram(o)uche-9/3/2004
401Cancer Res. 2004 Sep 1;64(17):6207-13. Ibuprofen Inhibits Survival of Bladderscaram(o)uche-9/3/2004
400Even if flurbie avoids tampering with Notch signaling at all doses, it affects ltuck-9/3/2004
3991. they've got a lead. 2. the molecule has been administered to humans, oscaram(o)uche-9/3/2004
398Well, if that conviction that Flurbie is sufficiently potent bears out next yeartuck-9/3/2004
397Someone is selling or shorting. We're back to that situation that the stockscaram(o)uche-9/3/2004
396my gosh, what a gem of an article. <i>If more potent compounds that use tscaram(o)uche-9/3/2004
395Veiled reference to Flurbie in this free Nature Reviews Neuroscience article: ntuck-9/3/2004
394not usually my focus, this is a cute little tickle (eortc-nci-aacr).... woensdascaram(o)uche-9/2/2004
393presenting at Bear Stearns 17th Annual Healthcare Conference, 9/14...... bearstscaram(o)uche-9/2/2004
392J Cell Physiol. 2004 Nov;201(2):167-80. The role of substance P in inflammatoscaram(o)uche-9/1/2004
391<i>I'm not certain why</i> Could be I've just gotten hold oBiomaven-8/31/2004
390We're not on the same page at all, and I'm not certain why. Full day, Iscaram(o)uche-8/31/2004
389I'm not worried about the tox at all. The question is do you want to try forBiomaven-8/31/2004
388>> and I'm not sure anyone really knows which effects you really want scaram(o)uche-8/31/2004
387Yes - I noted that part about the large discrepancies - I've seen it referreBiomaven-8/31/2004
386<i>Considering the poor potencies consistently observed in cellular and cescaram(o)uche-8/31/2004
385thanks for the full text pointer!..... <i>Considerable effort has been puscaram(o)uche-8/31/2004
384<i>Selected non-steroidal anti-inflammatory drugs and their derivatives taBiomaven-8/31/2004
383<i>buys about 90K shares and goes back over 5%</i>..... Item 2. (ascaram(o)uche-8/27/2004
382J Biol Chem. 2004 Aug 10 [Epub ahead of print] Selected non-steroidal anti-infscaram(o)uche-8/20/2004
3811st Alb: Myriad Genetics, Inc. (MYGN - $ 13.73) David Webber, Managing Dirmopgcw-8/19/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News